(Q33332127)

25 July 2017

title

Drug-Induced Thrombocytopenia: Is it a Serious Concern for Glycoprotein IIb/IIIa Receptor Inhibitors? (English)

1 reference

25 July 2017

1 reference

Giugliano RP

1

1 reference

25 July 2017

publication date

1 July 1998

1 reference

Journal of Thrombosis and Thrombolysis

25 July 2017

published in

1 reference

25 July 2017

volume

5

1 reference

25 July 2017

issue

3

1 reference

25 July 2017

page(s)

191-202

1 reference

Heparin-induced thrombocytopenia

25 July 2017

cites work

1 reference

12 December 2020

The pathogenesis of thrombocytopenic purpura due to hypersensitivity to sedormid

1 reference

12 December 2020

Heparin-induced thrombocytopenia

1 reference

12 December 2020

Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II

1 reference

12 December 2020

Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp

1 reference

12 December 2020

HAEMATOLOGICAL SIDE-EFFECTS OF SOME ANTI-RHEUMATIC DRUGS.

1 reference

12 December 2020

Thrombocytopenic reaction to aspirin and acetaminophen

1 reference

12 December 2020

Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial Infarction

1 reference

12 December 2020

Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgery. EPIC Investigators. Evaluation Prevention of Ischemic Complications

1 reference

12 December 2020

Heparin and Platelets

1 reference

12 December 2020

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

12 December 2020

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

12 December 2020

Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study

1 reference

12 December 2020

Ticlopidine and thrombocytopenia

1 reference

12 December 2020

Diagnostic and therapeutic strategies of white clot syndrome

1 reference

12 December 2020

Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group

1 reference

12 December 2020

Immunoreactions involving platelets. IV. Studies on the pathogenesis of thrombocytopenia in drug purpura using test doses of quinidine in sensitized individuals; their implications in idiopathic thrombocytopenic purpura

1 reference

12 December 2020

Aspirin-induced thrombocytopenia on an immune basis

1 reference

12 December 2020

Diagnosis and Treatment of Idiopathic Thrombocytopenic Purpura: Recommendations of the American Society of Hematology

1 reference

12 December 2020

Heparin-induced immune thrombocytopenia

1 reference

12 December 2020

Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

1 reference

12 December 2020

Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina. The Canadian Lamifiban Study

1 reference

12 December 2020

Heparin-induced thrombocytopenia: association with a platelet aggregating factor and arterial thromboses

1 reference

12 December 2020

Abciximab-associated profound thrombocytopenia: therapy with immunoglobulin and platelet transfusion

1 reference

12 December 2020

1 reference

12 December 2020

Differential dose-response to oral xemilofiban after antecedent intravenous abciximab. Administration for complex coronary intervention

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study

1 reference

12 December 2020

Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators

1 reference

12 December 2020

[Thrombocytopenia due to antibodies induced by ticlopidine]

1 reference

12 December 2020

Fatal effect of re-exposure to heparin after previous heparin-associated thrombocytopenia and thrombosis

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty.

1 reference

12 December 2020

Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1008887708104

1 reference

Dimensions Publication ID

25 July 2017

1028310016

0 references

1 reference